Systematic Review of Efficacy and Safety of Jingling Oral Liquid Combined with Methylphenidate Hydrochloride in the Treatment of Children with Attention Deficit Hyperactivity Disorder

ZHENG Zihui; PAN Huijie; CHEN Li; LI Wenying; MA Lin; ZHANG Baige; JIN Pengfei; ZHAO Zinan

doi:10.14009/j.issn.1672-2124.2021.01.017

您当前的位置：

首页 >

文章列表页 >

Systematic Review of Efficacy and Safety of Jingling Oral Liquid Combined with Methylphenidate Hydrochloride in the Treatment of Children with Attention Deficit Hyperactivity Disorder

更新时间：2022-10-08

- Systematic Review of Efficacy and Safety of Jingling Oral Liquid Combined with Methylphenidate Hydrochloride in the Treatment of Children with Attention Deficit Hyperactivity Disorder
- Vol. 21, Issue 1, Pages: 66-70(2021)
- 作者机构：
  
  1. 北京医院药学部药物临床风险与个体化应用评价北京市重点实验室
  2. 北京医院检验科国家老年医学中心中国医学科学院老年医学研究院
  3. 联合参谋部警卫局卫生保健处
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2021.01.017
  CLC： R749.94
- Published：2021，
扫描看全文
[1]郑子恢,潘慧杰,陈丽,李文英,马琳,张白鸽,金鹏飞,赵紫楠.静灵口服液联合盐酸哌甲酯治疗儿童注意缺陷多动障碍有效性和安全性的系统评价[J].中国医院用药评价与分析,2021,21(01):66-70.

ZHENG Zihui, PAN Huijie, CHEN Li, et al. Systematic Review of Efficacy and Safety of Jingling Oral Liquid Combined with Methylphenidate Hydrochloride in the Treatment of Children with Attention Deficit Hyperactivity Disorder. [J]. 21(1):66-70(2021)
[1]郑子恢,潘慧杰,陈丽,李文英,马琳,张白鸽,金鹏飞,赵紫楠.静灵口服液联合盐酸哌甲酯治疗儿童注意缺陷多动障碍有效性和安全性的系统评价[J].中国医院用药评价与分析,2021,21(01):66-70. DOI： 10.14009/j.issn.1672-2124.2021.01.017.

ZHENG Zihui, PAN Huijie, CHEN Li, et al. Systematic Review of Efficacy and Safety of Jingling Oral Liquid Combined with Methylphenidate Hydrochloride in the Treatment of Children with Attention Deficit Hyperactivity Disorder. [J]. 21(1):66-70(2021) DOI： 10.14009/j.issn.1672-2124.2021.01.017.

摘要

目的:系统评价静灵口服液联合盐酸哌甲酯治疗儿童注意缺陷多动障碍（attention deficit hyperactivity disorder

ADHD）的有效性和安全性

为中药治疗该病提供参考依据。方法:检索the Cochrane Library、Pub Med、EMBase、中国知网、万方数据库以及中国生物医学文献数据库

纳入静灵口服液联合盐酸哌甲酯（研究组）与单纯使用盐酸哌甲酯（对照组）分别治疗儿童ADHD的随机对照试验（randomized controlled trial

RCT）

检索时限从建库起至2020年9月。按纳入与排除标准筛选文献、提取资料并评估纳入研究的方法学质量后

采用Rev Man 5.4软件进行荟萃分析（Meta分析）。结果:共7项RCT纳入分析

涉及523例儿童ADHD患者

其中研究组患儿265例

对照组患儿258例;年龄7～15岁;对照组患儿单纯使用盐酸哌甲酯治疗

研究组患儿在对照组基础上加用静灵口服液。结局指标包括多动指数、显效率、总有效率和不良反应。Meta分析结果显示

两组患儿的显效率（RR=1.45

95%CI=1.26～1.72

P <0.01）、总有效率（RR=1.22

95%CI=1.13～1.33

P <0.01）、多动指数（MD=-0.7

95%CI=-8.53～-5.44

P <0.01）和不良反应发生率（RR=0.33

95%CI=0.17～0.64

P <0.01）比较

差异均有统计学意义

研究组患儿均优于对照组。结论:静灵口服液联合盐酸哌甲酯治疗儿童ADHD的有效性和安全性均高于单纯使用盐酸哌甲酯。

Abstract

OBJECTIVE: To systematically evaluate the efficacy and safety of Jingling oral liquid combined with methylphenidate hydrochloride in the treatment of children with attention deficit hyperactivity disorder（ ADHD）

so as to provide reference for the treatment of the disease with traditional Chinese medicine. METHODS: The Cochrane Library

PubMed

EMBase

CNKI

Wanfang database and CMB were retrieved to collect the randomized controlled trial（ RCT） of Jingling oral liquid combined with methylphenidate hydrochloride（ study group） and methylphenidate hydrochloride alone（ control group） in the treatment of children with ADHD. The retrieval time was from the establishment of the database to Sept. 2020. After screening the literature according to the inclusion and exclusion criteria

extracting the data and evaluating the methodological quality of the included literature

RevMan 5. 4 software was used for Meta-analysis. RESULTS: A total of 7 RCT were included

including 523 children with ADHD aged from7 to 15 years old

with 265 cases in the study group and 258 cases in the control group. The control group was treated with methylphenidate hydrochloride alone

while the study group received Jingling oral liquid on the basis of the control group. Outcome indicators included conners index of hyperactivity

significant efficiency

total efficiency and adverse drug reactions were analyzed. Meta-analysis results showed that the significant efficiency（ RR = 1. 45

95% CI = 1. 26-1. 72

P < 0. 01）

total efficiency（ RR = 1. 22

95% CI = 1. 13-1. 33

P < 0. 01）

conners index of hyperactivity（ MD =-0. 7

95% CI =-8. 53--5. 44

P < 0. 01） and adverse drug reactions（ RR = 0. 33

95% CI = 0. 17-0. 64

P < 0. 01）were statistically significantly different between two groups

and the study group was higher than the control group.CONCLUSIONS: The efficacy and safety of Jingling oral liquid combined with methylphenidate hydrochloride in the treatment of children with ADHD are higher than that of methylphenidate hydrochloride alone.

关键词

静灵口服液盐酸哌甲酯儿童注意缺陷多动障碍Meta分析随机对照试验

Keywords

Jingling oral liquidMethylphenidate hydrochlorideChildrenAttention deficit hyperactivity disorderMeta-analysisRandomized controlled trial

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Meta-Analysis of Efficacy and Safety of Ticagrelor Combined with Rosuvastatin Therapy in the Treatment of Unstable Angina Pectoris

Systematic Review of Efficacy and Safety of Linezolid in the Treatment of Drug-Resistant Tuberculosis

Systematic Review of Efficacy and Safety of Azelastine Hydrochloride Combined with Mometasone Furoate in the Treatment of Allergic Rhinitis

Systematic Review on Efficacy and Safety of Silybin Capsules in the Treatment of Fatty Liver Disease

Systematic Review on Efficacy and Safety of Compound Glycyrrhizin Injection in Adjuvant Treatment of Children with Henoch-Schonlein Purpura

Related Author

LUO Ruixiang

ZHANG Chen

WU Yang

FAN Zongjing

CUI Jie

DI Xuan

DONG Yiwen

WANG Weina

Related Institution

North District Branch,Beijing Emergency Medical Center

School of Clinical Medicine, Beijing University of Traditional Chinese Medicine

Dept. of Cardiology, Dongfang Hospital of Beijing University of Traditional Chinese Medicine

Dept. of Pharmacy, Beijing Friendship Hospital Affiliated to Capital Medical University

Dept. of Pharmacy, Beijing Hospital

⁰